Barclays PLC Novartis Ag Transaction History
Barclays PLC
- $288 Billion
- Q1 2024
A detailed history of Barclays PLC transactions in Novartis Ag stock. As of the latest transaction made, Barclays PLC holds 348 shares of NVS stock, worth $35,889. This represents 0.0% of its overall portfolio holdings.
Number of Shares
348
Previous 319
9.09%
Holding current value
$35,889
Previous $32,000
6.25%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding NVS
# of Institutions
1,342Shares Held
140MCall Options Held
1.15MPut Options Held
866K-
Primecap Management CO Pasadena, CA12.4MShares$1.28 Billion0.91% of portfolio
-
Dodge & Cox San Francisco, CA12.4MShares$1.27 Billion0.73% of portfolio
-
Morgan Stanley New York, NY7.26MShares$749 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX6.02MShares$621 Million0.16% of portfolio
-
Loomis Sayles & CO L P5.92MShares$610 Million0.81% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $222B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...